Insulet (PODD) Financials

$321.36 +0.36 (+0.11%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$322.26 +0.89 (+0.28%)

As of 05/23/2025 06:49 PM Eastern

Annual Income Statements for Insulet

This table shows Insulet's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	418	206	4.60	17	6.80	12	3.30	-27	-29	-74
Consolidated Net Income / (Loss)	418	206	4.60	17	6.80	12	3.30	-27	-29	-74
Net Income / (Loss) Continuing Operations	418	206	4.60	17	6.80	12	3.30	-27	-27	-62
Total Pre-Tax Income	300	215	9.80	21	9.70	15	5.20	-27	-27	-61
Total Operating Income	309	220	38	126	52	50	27	-7.40	-11	-49
Total Gross Profit	1,446	1,160	806	752	582	480	370	277	211	133
Total Revenue	2,072	1,697	1,305	1,099	904	738	564	464	367	264
Operating Revenue	2,072	1,697	1,305	1,099	904	738	564	464	367	264
Total Cost of Revenue	626	537	500	347	322	258	194	187	156	131
Operating Cost of Revenue	626	537	500	347	322	258	194	187	156	131
Total Operating Expenses	1,137	940	768	626	531	430	343	285	222	182
Selling, General & Admin Expense	917	735	588	466	384	298	248	85	72	60
Research & Development Expense	220	205	180	160	147	132	95	76	56	43
Total Other Income / (Expense), net	-8.70	-5.40	-28	-106	-42	-36	-22	-19	-16	-13
Interest Expense	43	36	36	104	45	36	21	22	17	13
Interest & Investment Income	40	29	9.30	0.50	-	-	-	-	-	-
Other Income / (Expense), net	-5.50	2.20	-1.10	-1.90	3.30	0.90	-0.90	2.60	0.83	0.06
Income Tax Expense	-118	8.30	5.20	3.70	2.90	2.90	1.90	0.20	0.39	0.21
Basic Earnings per Share	$5.97	$2.96	$0.07	$0.25	$0.11	$0.19	$0.06	($0.46)	($0.48)	-
Weighted Average Basic Shares Outstanding	70.08M	69.75M	69.38M	67.70M	64.74M	60.59M	58.86M	58.00M	57.25M	56.79M
Diluted Earnings per Share	$5.78	$2.94	$0.07	$0.24	$0.10	$0.19	$0.05	($0.46)	($0.48)	-
Weighted Average Diluted Shares Outstanding	73.89M	73.63M	69.91M	68.58M	65.95M	62.30M	61.01M	58.00M	57.25M	56.79M
Weighted Average Basic & Diluted Shares Outstanding	70.23M	69.93M	69.54M	69.22M	66.08M	62.86M	-19.40M	58.30M	57.25M	56.79M

This table shows Insulet's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	101	78	189	52	103	52	27	24	17	-5.20
Consolidated Net Income / (Loss)	101	78	189	52	103	52	27	24	17	-5.20
Net Income / (Loss) Continuing Operations	101	78	189	52	103	52	27	24	17	-5.20
Total Pre-Tax Income	111	83	51	55	108	54	29	25	22	-5.70
Total Operating Income	109	88	55	57	106	55	31	28	24	2.90
Total Gross Profit	431	377	331	307	361	293	265	241	217	188
Total Revenue	598	544	489	442	510	433	397	358	370	341
Operating Revenue	598	544	489	442	510	433	397	358	370	341
Total Cost of Revenue	167	167	158	135	149	139	132	118	152	153
Operating Cost of Revenue	167	167	158	135	149	139	132	118	152	153
Total Operating Expenses	322	289	276	250	255	239	234	213	194	185
Selling, General & Admin Expense	261	234	222	200	213	181	179	163	144	140
Research & Development Expense	61	55	54	50	42	58	55	50	50	45
Total Other Income / (Expense), net	2.00	-5.20	-3.50	-2.00	1.40	-1.10	-2.60	-3.10	-1.20	-8.60
Interest Expense	8.70	12	11	11	6.70	10	9.70	9.40	9.60	9.20
Interest & Investment Income	10	11	9.30	9.40	6.20	8.60	7.30	6.50	-	2.40
Other Income / (Expense), net	0.40	-3.40	-1.80	-0.70	1.90	0.70	-0.20	-0.20	1.50	-1.80
Income Tax Expense	11	5.40	-138	3.40	4.50	1.80	1.20	0.80	5.30	-0.50
Basic Earnings per Share	$1.43	$1.11	$2.69	$0.74	$1.49	$0.74	$0.39	$0.34	$0.25	($0.08)
Weighted Average Basic Shares Outstanding	70.08M	70.12M	70.06M	69.96M	69.75M	69.82M	69.74M	69.58M	69.38M	69.42M
Diluted Earnings per Share	$1.38	$1.08	$2.59	$0.73	$1.47	$0.74	$0.39	$0.34	$0.25	($0.08)
Weighted Average Diluted Shares Outstanding	73.89M	73.95M	73.80M	73.74M	73.63M	73.62M	70.14M	70.10M	69.91M	69.42M
Weighted Average Basic & Diluted Shares Outstanding	70.23M	70.14M	70.12M	70.04M	69.93M	69.83M	69.82M	69.70M	69.54M	69.45M

This table details how cash moves in and out of Insulet's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	249	15	-117	-116	708	100	-159	135	15	-29
Net Cash From Operating Activities	430	146	119	-68	84	98	36	41	16	-13
Net Cash From Continuing Operating Activities	427	146	119	-68	84	98	36	41	16	-13
Net Income / (Loss) Continuing Operations	418	206	4.60	17	6.80	12	3.30	-27	-29	-74
Consolidated Net Income / (Loss)	418	206	4.60	17	6.80	12	3.30	-27	-29	-74
Depreciation Expense	81	73	63	57	55	28	16	14	14	16
Amortization Expense	7.30	6.70	5.80	40	45	36	29	18	10	7.68
Non-Cash Adjustments To Reconcile Net Income	69	48	45	80	39	42	41	8.10	47	29
Changes in Operating Assets and Liabilities, net	-149	-188	0.30	-262	-63	-19	-53	28	-26	8.00
Net Cash From Investing Activities	-146	-119	-191	-83	14	-74	-185	-211	-178	-15
Net Cash From Continuing Investing Activities	-146	-119	-191	-83	14	-74	-185	-211	-178	-15
Purchase of Property, Plant & Equipment	-134	-84	-136	-123	-167	-164	-157	-74	-22	-11
Acquisitions	0.00	-28	-48	0.00	0.00	-7.20	-5.00	-3.40	-	-4.72
Purchase of Investments	-12	-7.20	-7.80	0.00	-38	-151	-191	-298	-178	0.00
Net Cash From Financing Activities	-28	-14	-40	41	606	74	-8.70	305	177	-0.37
Net Cash From Continuing Financing Activities	-28	-14	-40	41	606	74	-8.70	305	177	-0.37
Repayment of Debt	-56	-22	-20	-485	66	-664	-6.70	-99	-159	-5.58
Issuance of Debt	176	0.00	0.00	490	0.00	780	0.00	392	334	0.00
Issuance of Common Equity	12	11	9.40	8.10	484	4.30	0.00	16	4.85	7.85
Other Financing Activities, net	-159	-1.90	-30	28	56	-47	-2.00	-4.10	-2.87	-2.65
Effect of Exchange Rate Changes	-6.80	1.80	-4.30	-5.50	4.80	1.50	-1.40	-	0.03	-0.28

This table details how cash moves in and out of Insulet's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	51	82	70	47	19	25	24	-54	-47	13
Net Cash From Operating Activities	148	99	97	88	45	56	44	0.50	51	57
Net Cash From Continuing Operating Activities	144	99	97	88	44	57	44	0.50	51	57
Net Income / (Loss) Continuing Operations	101	78	189	52	103	52	27	24	17	-5.20
Consolidated Net Income / (Loss)	101	78	189	52	103	52	27	24	17	-5.20
Depreciation Expense	22	21	19	19	19	19	18	17	16	16
Amortization Expense	1.90	1.60	1.80	2.00	2.10	1.60	1.50	1.50	1.50	1.50
Non-Cash Adjustments To Reconcile Net Income	15	22	16	15	10	11	14	13	12	10
Changes in Operating Assets and Liabilities, net	4.40	-24	-130	-0.10	-90	-26	-17	-55	3.70	34
Net Cash From Investing Activities	-68	-29	-25	-24	-32	-23	-23	-42	-88	-34
Net Cash From Continuing Investing Activities	-68	-29	-25	-24	-32	-23	-23	-42	-88	-34
Purchase of Property, Plant & Equipment	-56	-29	-25	-24	-32	-22	-18	-12	-67	-34
Purchase of Investments	-12	-0.20	-	0.00	-	-0.20	-5.00	-2.00	-	-
Net Cash From Financing Activities	-21	7.80	-0.90	-14	2.20	-6.90	3.20	-12	-15	-3.90
Net Cash From Continuing Financing Activities	-21	7.80	-0.90	-14	2.20	-6.90	3.20	-12	-15	-3.90
Repayment of Debt	-16	-27	-5.60	-7.80	-5.50	-5.50	-5.90	-5.40	-4.90	-4.90
Issuance of Debt	13	-	-	-	-	-	-	-	-	-
Issuance of Common Equity	5.90	-	-	-	5.10	-	-	-	4.50	-
Other Financing Activities, net	-24	-128	-1.30	-6.30	2.60	-1.40	3.60	-6.70	-14	1.00
Effect of Exchange Rate Changes	-8.00	4.60	-0.90	-2.50	3.00	-1.20	0.10	-0.10	4.80	-5.60

This table presents Insulet's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	3,088	2,588	2,251	2,049	1,873	1,143	929	840	457	275
Total Current Assets	1,891	1,583	1,314	1,330	1,249	591	461	547	370	191
Cash & Equivalents	953	704	675	792	907	214	114	-	137	123
Accounts Receivable	366	360	206	161	95	69	77	5.12	29	43
Inventories, net	430	403	347	303	154	101	71	33	36	12
Prepaid Expenses	142	116	87	74	52	45	24	16	7.07	4.28
Plant, Property, & Equipment, net	723	665	600	537	479	399	258	0.00	45	42
Total Noncurrent Assets	473	340	337	183	146	153	209	15	42	43
Goodwill	52	52	52	40	40	40	40	-	40	40
Intangible Assets	99	99	76	37	29	13	10	-	2.04	0.93
Noncurrent Deferred & Refundable Income Taxes	142	1.80	-	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	182	188	210	106	77	41	18	15	0.22	0.08
Total Liabilities & Shareholders' Equity	3,088	2,588	2,251	2,049	1,873	1,143	929	840	457	275
Total Liabilities	1,876	1,856	1,775	1,493	1,269	1,067	717	661	393	241
Total Current Liabilities	528	451	365	229	208	158	116	89	56	65
Short-Term Debt	84	49	28	25	16	0.00	-	-	-	5.52
Accounts Payable	20	19	31	38	54	55	26	-	13	15
Accrued Expenses	425	383	306	166	138	103	90	-	41	37
Total Noncurrent Liabilities	1,348	1,404	1,410	1,264	1,062	909	601	6.30	338	176
Long-Term Debt	1,296	1,366	1,374	1,249	1,044	888	592	-	333	172
Other Noncurrent Operating Liabilities	52	38	36	15	18	21	8.90	6.30	5.03	3.95
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Equity & Noncontrolling Interests	1,212	733	476	556	604	76	212	-687	63	34
Total Preferred & Common Equity	1,212	733	476	556	604	76	212	179	63	34
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Common Equity	1,212	733	476	556	604	76	212	-687	63	34
Common Stock	1,185	1,103	1,041	1,208	1,264	749	899	-	744	686
Retained Earnings	40	-378	-584	-650	-666	-672	-684	-687	-680	-652
Accumulated Other Comprehensive Income / (Loss)	-13	8.00	20	-2.20	5.50	-1.20	-2.90	-	-0.73	-0.65

This table presents Insulet's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	3,088	3,025	2,882	2,624	2,588	2,468	2,386	2,289	2,251	2,166
Total Current Assets	1,891	1,861	1,749	1,618	1,583	1,471	1,422	1,330	1,314	1,329
Cash & Equivalents	953	903	821	751	704	685	660	621	675	722
Accounts Receivable	366	376	349	321	360	270	251	217	206	201
Inventories, net	430	445	431	431	403	411	411	386	347	328
Prepaid Expenses	142	138	148	116	116	105	100	106	87	78
Plant, Property, & Equipment, net	723	703	678	668	665	649	602	597	600	553
Total Noncurrent Assets	473	462	455	338	340	347	363	363	337	284
Goodwill	52	52	52	52	52	52	52	52	52	52
Intangible Assets	99	100	99	99	99	100	100	100	76	54
Noncurrent Deferred & Refundable Income Taxes	142	144	141	-	1.80	-	-	-	-	-
Other Noncurrent Operating Assets	182	166	164	188	188	196	212	211	210	179
Total Liabilities & Shareholders' Equity	3,088	3,025	2,882	2,624	2,588	2,468	2,386	2,289	2,251	2,166
Total Liabilities	1,876	1,907	1,883	1,833	1,856	1,860	1,832	1,786	1,775	1,738
Total Current Liabilities	528	506	486	432	451	451	425	383	365	334
Short-Term Debt	84	42	38	39	49	50	29	28	28	27
Accounts Payable	20	40	77	76	19	78	108	86	31	62
Accrued Expenses	425	424	371	318	383	324	288	270	306	245
Total Noncurrent Liabilities	1,348	1,401	1,397	1,401	1,404	1,409	1,407	1,403	1,410	1,404
Long-Term Debt	1,296	1,356	1,360	1,363	1,366	1,371	1,369	1,369	1,374	1,380
Other Noncurrent Operating Liabilities	52	45	37	38	38	38	38	34	36	24
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,212	1,118	998	791	733	608	554	503	476	428
Total Preferred & Common Equity	1,212	1,118	998	791	733	608	554	503	476	428
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,212	1,118	998	791	733	608	554	503	476	428
Common Stock	1,185	1,159	1,141	1,118	1,103	1,081	1,071	1,047	1,041	1,023
Retained Earnings	40	-60	-138	-327	-378	-481	-533	-561	-584	-601
Accumulated Other Comprehensive Income / (Loss)	-13	20	-4.40	-0.50	8.00	7.60	16	16	20	6.80

This table displays calculated financial ratios and metrics derived from Insulet's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	22.07%	30.02%	18.79%	21.49%	22.51%	30.93%	21.56%	26.38%	39.07%	14.08%
EBITDA Growth	29.76%	185.97%	-52.41%	42.66%	35.84%	60.22%	163.47%	93.27%	155.73%	-303.30%
EBIT Growth	36.54%	508.77%	-70.59%	126.46%	7.66%	92.08%	652.08%	51.41%	79.71%	-382.01%
NOPAT Growth	103.52%	1,098.32%	-82.91%	186.01%	-9.74%	130.04%	435.68%	30.87%	78.04%	-449.20%
Net Income Growth	102.76%	4,384.78%	-72.62%	147.06%	-41.38%	251.52%	112.31%	7.20%	60.72%	-42.76%
EPS Growth	96.60%	4,100.00%	-70.83%	140.00%	-47.37%	280.00%	110.87%	4.17%	0.00%	0.00%
Operating Cash Flow Growth	195.33%	22.44%	274.74%	-181.07%	-14.63%	174.09%	-13.08%	159.57%	226.76%	-240.72%
Free Cash Flow Firm Growth	907.34%	80.10%	33.08%	-46.80%	-30.46%	61.61%	-968.13%	257.69%	-47.81%	-23.65%
Invested Capital Growth	13.42%	20.01%	15.88%	45.20%	35.14%	41.37%	549.00%	-40.74%	17.32%	-18.89%
Revenue Q/Q Growth	4.42%	9.00%	4.99%	5.94%	4.23%	6.42%	6.48%	6.18%	5.70%	35.15%
EBITDA Q/Q Growth	1.01%	40.20%	-22.03%	22.83%	-4.66%	17.38%	21.10%	28.64%	227.08%	-97.18%
EBIT Q/Q Growth	0.46%	59.97%	-39.97%	80.38%	-30.90%	19.74%	58.37%	46.43%	47.15%	-39.88%
NOPAT Q/Q Growth	-0.85%	65.96%	-65.59%	113.79%	-43.14%	-6.47%	138.65%	31.19%	44.21%	-39.44%
Net Income Q/Q Growth	-0.62%	71.92%	-72.62%	156.95%	-76.47%	-29.70%	124.57%	7.87%	38.67%	-42.50%
EPS Q/Q Growth	-1.53%	70.93%	-72.00%	153.33%	-77.78%	26.67%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	31.27%	-3.64%	178.04%	-166.02%	-26.25%	20.09%	31.25%	4.62%	169.93%	-217.86%
Free Cash Flow Firm Q/Q Growth	45.26%	71.37%	-9.30%	15.07%	-167.80%	-4.45%	-52.47%	189.43%	37.95%	-123.70%
Invested Capital Q/Q Growth	1.51%	7.58%	8.16%	12.08%	15.50%	5.90%	7.88%	-59.78%	-13.41%	-8.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.79%	68.35%	61.72%	68.45%	64.39%	65.06%	65.66%	59.77%	57.52%	50.50%
EBITDA Margin	18.90%	17.78%	8.08%	20.18%	17.18%	15.50%	12.66%	5.84%	3.82%	-9.53%
Operating Margin	14.91%	12.96%	2.88%	11.47%	5.69%	6.77%	4.86%	-1.60%	-2.92%	-18.47%
EBIT Margin	14.65%	13.09%	2.80%	11.29%	6.06%	6.90%	4.70%	-1.03%	-2.69%	-18.45%
Profit (Net Income) Margin	20.19%	12.16%	0.35%	1.53%	0.75%	1.57%	0.59%	-5.78%	-7.87%	-27.86%
Tax Burden Percent	139.34%	96.13%	46.94%	81.95%	70.10%	80.00%	63.46%	100.75%	107.69%	119.76%
Interest Burden Percent	98.95%	96.58%	26.85%	16.52%	17.70%	28.49%	19.62%	554.17%	271.46%	126.11%
Effective Tax Rate	-39.34%	3.87%	53.06%	18.05%	29.90%	20.00%	36.54%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	27.93%	15.97%	1.57%	11.77%	5.80%	8.85%	8.05%	-6.68%	-8.31%	-36.83%
ROIC Less NNEP Spread (ROIC-NNEP)	25.80%	15.25%	-0.58%	-17.34%	-4.57%	-0.37%	4.94%	-12.23%	-59.77%	-153.76%
Return on Net Nonoperating Assets (RNNOA)	15.10%	18.15%	-0.68%	-8.88%	-3.80%	-0.80%	-9.44%	15.28%	-51.11%	-87.91%
Return on Equity (ROE)	43.03%	34.12%	0.89%	2.90%	2.00%	8.06%	-1.39%	8.59%	-59.42%	-124.74%
Cash Return on Invested Capital (CROIC)	15.35%	-2.21%	-13.14%	-25.09%	-24.09%	-25.43%	-138.55%	44.48%	-24.25%	-15.97%
Operating Return on Assets (OROA)	10.69%	9.18%	1.70%	6.33%	3.63%	4.91%	3.00%	-0.74%	-2.70%	-17.01%
Return on Assets (ROA)	14.74%	8.53%	0.21%	0.86%	0.45%	1.12%	0.37%	-4.13%	-7.89%	-25.69%
Return on Common Equity (ROCE)	43.03%	34.12%	0.89%	2.90%	2.00%	8.06%	-1.39%	8.59%	-59.42%	-124.74%
Return on Equity Simple (ROE_SIMPLE)	34.52%	28.16%	0.97%	3.02%	1.13%	15.28%	1.56%	-14.98%	-45.73%	-215.91%
Net Operating Profit after Tax (NOPAT)	430	211	18	103	36	40	17	-5.18	-7.49	-34
NOPAT Margin	20.78%	12.46%	1.35%	9.40%	3.99%	5.42%	3.08%	-1.12%	-2.04%	-12.93%
Net Nonoperating Expense Percent (NNEP)	2.13%	0.72%	2.16%	29.11%	10.37%	9.23%	3.11%	5.55%	51.46%	116.94%
Return On Investment Capital (ROIC_SIMPLE)	16.61%	9.84%	0.94%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	30.21%	31.65%	38.28%	31.55%	35.61%	34.94%	34.34%	40.23%	42.48%	49.50%
SG&A Expenses to Revenue	44.28%	43.30%	45.03%	42.41%	42.46%	40.37%	43.99%	18.26%	19.51%	22.89%
R&D to Revenue	10.60%	12.08%	13.81%	14.57%	16.23%	17.92%	16.81%	16.32%	15.18%	16.37%
Operating Expenses to Revenue	54.88%	55.38%	58.84%	56.98%	58.69%	58.29%	60.80%	61.36%	60.44%	68.97%
Earnings before Interest and Taxes (EBIT)	303	222	37	124	55	51	27	-4.80	-9.88	-49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	392	302	106	222	155	114	71	27	14	-25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	15.11	20.68	42.92	32.99	27.92	139.44	22.09	0.00	34.26	63.21
Price to Tangible Book Value (P/TBV)	17.25	26.02	58.55	38.24	31.50	462.18	28.91	0.00	100.96	0.00
Price to Revenue (P/Rev)	8.84	8.93	15.66	16.70	18.63	14.34	8.31	8.66	5.90	8.16
Price to Earnings (P/E)	43.78	73.44	4,444.57	1,092.27	2,478.40	912.40	1,420.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.28%	1.36%	0.02%	0.09%	0.04%	0.11%	0.07%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	11.44	10.98	17.59	18.13	23.72	20.85	12.95	69.60	22.58	26.60
Enterprise Value to Revenue (EV/Rev)	9.05	9.35	16.22	17.14	18.76	14.95	8.60	8.66	5.99	8.36
Enterprise Value to EBITDA (EV/EBITDA)	47.87	52.58	200.68	84.95	109.17	96.48	67.90	148.15	156.75	0.00
Enterprise Value to EBIT (EV/EBIT)	61.76	71.39	580.06	151.75	309.58	216.84	182.96	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	43.54	75.00	1,199.62	182.38	469.90	275.93	278.82	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	43.55	108.87	177.92	0.00	201.96	112.17	135.05	97.21	138.14	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	79.19	0.00	0.00	0.00	0.00	0.00	0.00	116.45	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.14	1.93	2.94	2.29	1.76	11.70	2.79	0.00	5.27	5.21
Long-Term Debt to Equity	1.07	1.86	2.88	2.24	1.73	11.70	2.79	0.00	5.27	5.05
Financial Leverage	0.59	1.19	1.17	0.51	0.83	2.14	-1.91	-1.25	0.86	0.57
Leverage Ratio	2.92	4.00	4.16	3.38	4.44	7.19	-3.73	-2.08	7.53	4.86
Compound Leverage Factor	2.89	3.87	1.12	0.56	0.79	2.05	-0.73	-11.52	20.44	6.12
Debt to Total Capital	53.25%	65.90%	74.64%	69.60%	63.70%	92.12%	73.62%	0.00%	84.05%	83.90%
Short-Term Debt to Total Capital	3.23%	2.30%	1.46%	1.37%	0.94%	0.00%	0.00%	0.00%	0.00%	2.61%
Long-Term Debt to Total Capital	50.01%	63.60%	73.17%	68.23%	62.76%	92.12%	73.62%	0.00%	84.05%	81.29%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.75%	34.10%	25.36%	30.40%	36.30%	7.88%	26.38%	100.00%	15.95%	16.10%
Debt to EBITDA	3.52	4.69	13.29	5.75	6.82	7.76	8.29	0.00	23.73	-7.05
Net Debt to EBITDA	1.09	2.36	6.89	2.18	0.72	3.96	2.27	0.00	2.44	-2.18
Long-Term Debt to EBITDA	3.31	4.53	13.03	5.63	6.72	7.76	8.29	0.00	23.73	-6.83
Debt to NOPAT	3.21	6.69	79.43	12.34	29.34	22.20	34.05	0.00	-44.41	-5.20
Net Debt to NOPAT	0.99	3.36	41.20	4.67	3.09	11.34	9.33	0.00	-4.56	-1.61
Long-Term Debt to NOPAT	3.01	6.46	77.87	12.09	28.91	22.20	34.05	0.00	-44.41	-5.04
Altman Z-Score	7.40	6.16	7.69	8.31	8.71	6.38	4.04	3.69	2.77	2.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.58	3.51	3.60	5.81	6.01	3.75	3.99	6.17	6.64	2.93
Quick Ratio	2.50	2.36	2.41	4.16	5.02	2.82	3.16	0.06	5.88	2.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	237	-29	-147	-220	-150	-115	-299	34	-22	-15
Operating Cash Flow to CapEx	321.12%	173.25%	87.63%	-55.50%	50.45%	60.11%	22.81%	55.96%	71.95%	-118.33%
Free Cash Flow to Firm to Interest Expense	5.54	-0.81	-4.09	-2.11	-3.32	-3.16	-14.05	1.58	-1.29	-1.16
Operating Cash Flow to Interest Expense	10.08	4.02	3.31	-0.65	1.86	2.70	1.69	1.89	0.94	-0.99
Operating Cash Flow Less CapEx to Interest Expense	6.94	1.70	-0.47	-1.83	-1.83	-1.79	-5.70	-1.49	-0.37	-1.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.70	0.61	0.56	0.60	0.71	0.64	0.72	1.00	0.92
Accounts Receivable Turnover	5.71	6.00	7.12	8.57	10.99	10.11	13.78	27.35	10.29	6.40
Inventory Turnover	1.50	1.43	1.54	1.52	2.52	2.99	3.71	5.44	6.56	10.40
Fixed Asset Turnover	2.99	2.68	2.30	2.16	2.06	2.24	0.00	0.00	8.48	6.69
Accounts Payable Turnover	32.10	21.49	14.59	7.55	5.93	6.45	0.00	0.00	10.99	8.75
Days Sales Outstanding (DSO)	63.89	60.79	51.26	42.57	33.21	36.09	26.48	13.35	35.47	56.99
Days Inventory Outstanding (DIO)	242.89	254.59	237.39	240.82	144.65	122.00	98.45	67.05	55.65	35.10
Days Payable Outstanding (DPO)	11.37	16.99	25.02	48.32	61.53	56.61	0.00	0.00	33.21	41.74
Cash Conversion Cycle (CCC)	295.40	298.39	263.63	235.07	116.33	101.48	124.94	80.40	57.91	50.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,638	1,444	1,204	1,039	715	529	374	58	97	83
Invested Capital Turnover	1.34	1.28	1.16	1.25	1.45	1.63	2.61	5.98	4.07	2.85
Increase / (Decrease) in Invested Capital	194	241	165	323	186	155	317	-40	14	-19
Enterprise Value (EV)	18,739	15,863	21,172	18,832	16,965	11,037	4,848	4,015	2,198	2,207
Market Capitalization	18,313	15,151	20,445	18,350	16,853	10,584	4,686	4,015	2,164	2,152
Book Value per Share	$17.27	$10.49	$6.86	$8.07	$9.16	$1.23	$3.59	($11.81)	$1.10	$0.60
Tangible Book Value per Share	$15.13	$8.34	$5.03	$6.96	$8.12	$0.37	$2.74	($11.81)	$0.37	($0.11)
Total Capital	2,592	2,149	1,878	1,830	1,663	964	804	-687	396	212
Total Debt	1,380	1,416	1,402	1,274	1,059	888	592	0.00	333	177
Total Long-Term Debt	1,296	1,366	1,374	1,249	1,044	888	592	0.00	333	172
Net Debt	427	712	727	482	112	453	162	0.00	34	55
Capital Expenditures (CapEx)	134	84	136	123	167	164	157	74	22	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	493	477	302	335	109	57	57	458	16	8.45
Debt-free Net Working Capital (DFNWC)	1,447	1,181	977	1,126	1,057	433	346	458	314	131
Net Working Capital (NWC)	1,363	1,132	949	1,101	1,041	433	346	458	314	126
Net Nonoperating Expense (NNE)	12	5.19	13	86	29	28	14	22	21	39
Net Nonoperating Obligations (NNO)	427	712	727	482	112	453	162	745	34	49
Total Depreciation and Amortization (D&A)	88	80	69	98	101	64	45	32	24	24
Debt-free, Cash-free Net Working Capital to Revenue	23.81%	28.10%	23.14%	30.44%	12.04%	7.75%	10.06%	98.85%	4.28%	3.20%
Debt-free Net Working Capital to Revenue	69.83%	69.60%	74.83%	102.48%	116.82%	58.70%	61.30%	98.85%	85.63%	49.69%
Net Working Capital to Revenue	65.79%	66.68%	72.73%	100.20%	115.09%	58.70%	61.30%	98.85%	85.63%	47.60%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.97	$2.96	$0.07	$0.25	$0.11	$0.19	$0.06	$0.00	$0.00	($1.29)
Adjusted Weighted Average Basic Shares Outstanding	70.08M	69.75M	69.38M	67.70M	64.74M	60.59M	58.86M	58.39M	57.65M	57.02M
Adjusted Diluted Earnings per Share	$5.78	$2.94	$0.07	$0.24	$0.10	$0.19	$0.05	$0.00	$0.00	($1.29)
Adjusted Weighted Average Diluted Shares Outstanding	73.89M	73.63M	69.91M	68.58M	65.95M	62.30M	61.01M	58.39M	57.65M	57.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($1.29)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	70.23M	69.93M	69.54M	69.22M	66.08M	62.86M	59.28M	58.00M	57.25M	56.79M
Normalized Net Operating Profit after Tax (NOPAT)	216	211	26	103	36	40	17	-5.18	-7.49	-34
Normalized NOPAT Margin	10.44%	12.46%	2.02%	9.40%	3.99%	5.42%	3.08%	-1.12%	-2.04%	-12.93%
Pre Tax Income Margin	14.49%	12.65%	0.75%	1.87%	1.07%	1.96%	0.92%	-5.74%	-7.31%	-23.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.11	6.14	1.01	1.19	1.22	1.40	1.24	-0.22	-0.58	-3.83
NOPAT to Interest Expense	10.08	5.84	0.49	0.99	0.80	1.10	0.82	-0.24	-0.44	-2.68
EBIT Less CapEx to Interest Expense	3.97	3.81	-2.76	0.01	-2.48	-3.10	-6.15	-3.61	-1.89	-4.66
NOPAT Less CapEx to Interest Expense	6.94	3.52	-3.28	-0.19	-2.89	-3.40	-6.57	-3.62	-1.75	-3.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Insulet's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.20%	25.70%	23.20%	23.35%	37.90%	26.97%	32.43%	21.23%	20.15%	23.66%
EBITDA Growth	3.02%	41.95%	46.14%	66.67%	202.58%	309.73%	571.96%	-16.00%	-41.10%	-66.91%
EBIT Growth	1.29%	52.61%	70.87%	104.36%	333.20%	4,945.45%	211.15%	-28.01%	-49.29%	-96.67%
NOPAT Growth	-3.01%	55.51%	576.45%	99.17%	469.13%	2,509.02%	259.39%	-25.47%	-58.77%	-92.73%
Net Income Growth	-2.52%	49.33%	590.84%	116.39%	507.65%	1,098.08%	178.00%	-14.39%	-41.78%	-141.27%
EPS Growth	-6.12%	45.95%	564.10%	114.71%	488.00%	1,025.00%	178.00%	-15.00%	-41.86%	-144.44%
Operating Cash Flow Growth	226.77%	75.89%	119.32%	17,420.00%	-10.85%	-1.23%	73.91%	103.65%	298.82%	319.77%
Free Cash Flow Firm Growth	31.64%	-6.79%	39.87%	-11.95%	5.54%	3.88%	54.63%	69.23%	47.48%	34.17%
Invested Capital Growth	13.42%	20.20%	21.96%	12.69%	20.01%	20.65%	14.78%	10.75%	15.88%	20.07%
Revenue Q/Q Growth	9.85%	11.34%	10.60%	-13.36%	17.82%	9.13%	10.72%	-3.14%	8.48%	13.83%
EBITDA Q/Q Growth	23.70%	45.80%	-4.16%	-40.40%	70.45%	50.10%	9.31%	8.20%	130.81%	272.90%
EBIT Q/Q Growth	29.52%	60.42%	-6.05%	-48.11%	95.14%	79.61%	12.36%	10.00%	2,172.73%	103.96%
NOPAT Q/Q Growth	20.07%	-59.13%	277.54%	-47.65%	92.51%	77.79%	11.16%	49.59%	782.50%	110.86%
Net Income Q/Q Growth	29.94%	-58.91%	266.21%	-50.15%	99.04%	90.11%	14.71%	40.00%	426.92%	85.14%
EPS Q/Q Growth	27.78%	-58.30%	254.79%	-50.34%	98.65%	89.74%	14.71%	36.00%	412.50%	84.00%
Operating Cash Flow Q/Q Growth	49.95%	2.07%	10.16%	93.81%	-19.29%	27.27%	8,700.00%	-99.01%	-10.58%	124.11%
Free Cash Flow Firm Q/Q Growth	49.74%	-130.06%	24.64%	21.55%	21.49%	-29.54%	-40.30%	33.80%	20.10%	38.86%
Invested Capital Q/Q Growth	1.51%	2.44%	9.31%	-0.23%	7.58%	3.94%	1.01%	6.25%	8.16%	-1.12%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	72.12%	69.33%	67.74%	69.46%	70.85%	67.78%	66.81%	67.16%	58.78%	55.25%
EBITDA Margin	22.28%	19.78%	15.11%	17.43%	25.34%	17.52%	12.74%	12.90%	11.55%	5.43%
Operating Margin	18.29%	16.20%	11.18%	12.88%	20.87%	12.66%	7.84%	7.74%	6.36%	0.85%
EBIT Margin	18.36%	15.57%	10.81%	12.72%	21.24%	12.83%	7.79%	7.68%	6.76%	0.32%
Profit (Net Income) Margin	16.85%	14.25%	38.61%	11.66%	20.26%	11.99%	6.89%	6.65%	4.60%	-1.53%
Tax Burden Percent	90.48%	93.49%	369.08%	93.81%	95.83%	96.65%	95.79%	96.75%	76.23%	91.23%
Interest Burden Percent	101.46%	97.87%	96.78%	97.69%	99.54%	96.76%	92.23%	89.45%	89.20%	-518.18%
Effective Tax Rate	9.52%	6.51%	-269.08%	6.19%	4.17%	3.35%	4.21%	3.25%	23.77%	0.00%
Return on Invested Capital (ROIC)	22.25%	20.32%	53.90%	15.82%	25.64%	15.52%	9.11%	8.41%	5.64%	0.73%
ROIC Less NNEP Spread (ROIC-NNEP)	22.56%	19.53%	51.93%	15.56%	25.82%	15.37%	8.76%	8.01%	5.49%	-0.57%
Return on Net Nonoperating Assets (RNNOA)	13.21%	13.93%	43.97%	17.16%	30.73%	21.08%	12.93%	12.52%	6.43%	-0.69%
Return on Equity (ROE)	35.45%	34.26%	97.87%	32.98%	56.37%	36.60%	22.04%	20.93%	12.07%	0.04%
Cash Return on Invested Capital (CROIC)	15.35%	11.02%	8.33%	5.57%	-2.21%	-8.34%	-7.40%	-9.94%	-13.14%	-13.21%
Operating Return on Assets (OROA)	13.40%	11.25%	7.69%	9.22%	14.90%	8.62%	5.08%	4.82%	4.11%	0.19%
Return on Assets (ROA)	12.30%	10.29%	27.45%	8.45%	14.21%	8.06%	4.48%	4.17%	2.79%	-0.91%
Return on Common Equity (ROCE)	35.45%	34.26%	97.87%	32.98%	56.37%	36.60%	22.04%	20.93%	12.07%	0.04%
Return on Equity Simple (ROE_SIMPLE)	0.00%	37.65%	39.59%	29.59%	0.00%	19.75%	11.36%	0.12%	0.00%	3.93%
Net Operating Profit after Tax (NOPAT)	99	82	202	53	102	53	30	27	18	2.03
NOPAT Margin	16.55%	15.14%	41.25%	12.08%	20.00%	12.24%	7.51%	7.48%	4.85%	0.60%
Net Nonoperating Expense Percent (NNEP)	-0.32%	0.79%	1.97%	0.26%	-0.19%	0.15%	0.35%	0.40%	0.15%	1.30%
Return On Investment Capital (ROIC_SIMPLE)	3.82%	-	-	-	4.75%	-	-	-	0.95%	-
Cost of Revenue to Revenue	27.88%	30.67%	32.26%	30.54%	29.15%	32.22%	33.19%	32.84%	41.22%	44.75%
SG&A Expenses to Revenue	43.68%	43.04%	45.53%	45.21%	41.74%	41.76%	45.07%	45.43%	39.03%	41.20%
R&D to Revenue	10.14%	10.09%	11.03%	11.37%	8.24%	13.36%	13.90%	13.99%	13.39%	13.20%
Operating Expenses to Revenue	53.82%	53.13%	56.56%	56.58%	49.98%	55.12%	58.97%	59.42%	52.42%	54.40%
Earnings before Interest and Taxes (EBIT)	110	85	53	56	108	56	31	28	25	1.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	133	108	74	77	129	76	51	46	43	19
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	15.11	14.60	14.16	15.14	20.68	18.33	36.28	44.12	42.92	37.20
Price to Tangible Book Value (P/TBV)	17.25	16.88	16.66	18.69	26.02	24.40	49.90	63.21	58.55	49.34
Price to Revenue (P/Rev)	8.84	8.23	7.55	6.72	8.93	7.15	13.72	16.21	15.66	12.81
Price to Earnings (P/E)	43.78	38.77	35.76	51.15	73.44	92.80	319.49	36,968.66	4,444.57	947.69
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.28%	2.58%	2.80%	1.96%	1.36%	1.08%	0.31%	0.00%	0.02%	0.11%
Enterprise Value to Invested Capital (EV/IC)	11.44	10.42	9.34	8.76	10.98	8.84	16.13	17.95	17.59	14.92
Enterprise Value to Revenue (EV/Rev)	9.05	8.48	7.86	7.09	9.35	7.62	14.22	16.78	16.22	13.36
Enterprise Value to EBITDA (EV/EBITDA)	47.87	43.38	41.35	37.95	52.58	55.16	131.94	237.41	200.68	122.73
Enterprise Value to EBIT (EV/EBIT)	61.76	55.68	53.93	50.29	71.39	85.46	246.55	889.81	580.06	273.12
Enterprise Value to NOPAT (EV/NOPAT)	43.54	38.74	36.50	53.00	75.00	93.15	270.96	7,121.73	1,199.62	323.80
Enterprise Value to Operating Cash Flow (EV/OCF)	43.55	51.30	51.56	54.20	108.87	78.51	137.15	172.35	177.92	387.99
Enterprise Value to Free Cash Flow (EV/FCFF)	79.19	103.23	123.22	166.46	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.14	1.25	1.40	1.77	1.93	2.34	2.52	2.78	2.94	3.29
Long-Term Debt to Equity	1.07	1.21	1.36	1.72	1.86	2.26	2.47	2.72	2.88	3.22
Financial Leverage	0.59	0.71	0.85	1.10	1.19	1.37	1.48	1.56	1.17	1.20
Leverage Ratio	2.92	3.18	3.39	3.80	4.00	4.48	4.61	4.59	4.16	4.50
Compound Leverage Factor	2.96	3.12	3.28	3.71	3.98	4.33	4.25	4.11	3.71	-23.31
Debt to Total Capital	53.25%	55.57%	58.33%	63.93%	65.90%	70.04%	71.62%	73.53%	74.64%	76.67%
Short-Term Debt to Total Capital	3.23%	1.67%	1.58%	1.77%	2.30%	2.46%	1.50%	1.46%	1.46%	1.47%
Long-Term Debt to Total Capital	50.01%	53.90%	56.75%	62.16%	63.60%	67.59%	70.12%	72.06%	73.17%	75.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.75%	44.43%	41.67%	36.07%	34.10%	29.96%	28.38%	26.47%	25.36%	23.33%
Debt to EBITDA	3.52	3.61	3.93	4.22	4.69	6.60	8.85	14.44	13.29	10.40
Net Debt to EBITDA	1.09	1.28	1.62	1.96	2.36	3.42	4.67	8.02	6.89	5.06
Long-Term Debt to EBITDA	3.31	3.50	3.82	4.10	4.53	6.37	8.67	14.16	13.03	10.20
Debt to NOPAT	3.21	3.22	3.47	5.89	6.69	11.15	18.18	433.25	79.43	27.43
Net Debt to NOPAT	0.99	1.14	1.43	2.73	3.36	5.77	9.59	240.70	41.20	13.35
Long-Term Debt to NOPAT	3.01	3.12	3.37	5.72	6.46	10.76	17.80	424.63	77.87	26.91
Altman Z-Score	7.19	6.39	5.67	5.03	6.01	4.52	7.43	8.24	7.67	6.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.58	3.68	3.60	3.74	3.51	3.26	3.34	3.47	3.60	3.98
Quick Ratio	2.50	2.53	2.41	2.48	2.36	2.12	2.14	2.19	2.41	2.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-95	-189	-82	-109	-139	-177	-137	-97	-147	-184
Operating Cash Flow to CapEx	263.75%	338.49%	387.55%	365.00%	143.04%	250.00%	243.09%	4.17%	75.78%	167.26%
Free Cash Flow to Firm to Interest Expense	-10.91	-15.35	-7.46	-10.18	-20.72	-17.00	-14.07	-10.35	-15.31	-20.00
Operating Cash Flow to Interest Expense	16.98	8.01	8.77	8.19	6.75	5.38	4.54	0.05	5.28	6.16
Operating Cash Flow Less CapEx to Interest Expense	10.54	5.64	6.51	5.94	2.03	3.23	2.67	-1.22	-1.69	2.48
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.72	0.71	0.72	0.70	0.67	0.65	0.63	0.61	0.60
Accounts Receivable Turnover	5.71	6.14	6.25	6.62	6.00	6.60	6.41	6.73	7.12	7.88
Inventory Turnover	1.50	1.42	1.38	1.36	1.43	1.47	1.51	1.52	1.54	1.51
Fixed Asset Turnover	2.99	2.93	2.93	2.82	2.68	2.59	2.58	2.41	2.30	2.33
Accounts Payable Turnover	32.10	10.29	6.30	6.85	21.49	7.73	6.73	7.70	14.59	7.36
Days Sales Outstanding (DSO)	63.89	59.42	58.38	55.11	60.79	55.29	56.94	54.23	51.26	46.34
Days Inventory Outstanding (DIO)	242.89	256.89	264.77	268.80	254.59	249.09	240.99	240.62	237.39	242.31
Days Payable Outstanding (DPO)	11.37	35.46	57.94	53.25	16.99	47.19	54.25	47.41	25.02	49.61
Cash Conversion Cycle (CCC)	295.40	280.85	265.22	270.65	298.39	257.19	243.69	247.44	263.63	239.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,638	1,614	1,575	1,441	1,444	1,343	1,292	1,279	1,204	1,113
Invested Capital Turnover	1.34	1.34	1.31	1.31	1.28	1.27	1.21	1.12	1.16	1.22
Increase / (Decrease) in Invested Capital	194	271	284	162	241	230	166	124	165	186
Enterprise Value (EV)	18,739	16,815	14,711	12,619	15,863	11,871	20,834	22,957	21,172	16,606
Market Capitalization	18,313	16,319	14,134	11,968	15,151	11,136	20,096	22,181	20,445	15,921
Book Value per Share	$17.27	$15.95	$14.25	$11.30	$10.49	$8.70	$7.95	$7.23	$6.86	$6.17
Tangible Book Value per Share	$15.13	$13.79	$12.11	$9.16	$8.34	$6.54	$5.78	$5.05	$5.03	$4.65
Total Capital	2,592	2,516	2,396	2,192	2,149	2,028	1,952	1,899	1,878	1,835
Total Debt	1,380	1,398	1,398	1,402	1,416	1,420	1,398	1,397	1,402	1,407
Total Long-Term Debt	1,296	1,356	1,360	1,363	1,366	1,371	1,369	1,369	1,374	1,380
Net Debt	427	496	577	650	712	735	738	776	727	685
Capital Expenditures (CapEx)	56	29	25	24	32	22	18	12	67	34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	493	494	480	474	477	384	366	354	302	300
Debt-free Net Working Capital (DFNWC)	1,447	1,397	1,301	1,225	1,181	1,070	1,026	975	977	1,022
Net Working Capital (NWC)	1,363	1,355	1,263	1,186	1,132	1,020	997	947	949	995
Net Nonoperating Expense (NNE)	-1.81	4.86	13	1.88	-1.34	1.06	2.49	3.00	0.91	7.23
Net Nonoperating Obligations (NNO)	427	496	577	650	712	735	738	776	727	685
Total Depreciation and Amortization (D&A)	23	23	21	21	21	20	20	19	18	17
Debt-free, Cash-free Net Working Capital to Revenue	23.81%	24.91%	25.62%	26.60%	28.10%	24.67%	24.95%	25.86%	23.14%	24.11%
Debt-free Net Working Capital to Revenue	69.83%	70.40%	69.46%	68.79%	69.60%	68.69%	70.01%	71.24%	74.83%	82.18%
Net Working Capital to Revenue	65.79%	68.28%	67.43%	66.60%	66.68%	65.49%	68.02%	69.20%	72.73%	80.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.43	$1.11	$2.69	$0.74	$1.49	$0.74	$0.39	$0.34	$0.25	($0.08)
Adjusted Weighted Average Basic Shares Outstanding	70.08M	70.12M	70.06M	69.96M	69.75M	69.82M	69.74M	69.58M	69.38M	69.42M
Adjusted Diluted Earnings per Share	$1.38	$1.08	$2.59	$0.73	$1.47	$0.74	$0.39	$0.34	$0.25	($0.08)
Adjusted Weighted Average Diluted Shares Outstanding	73.89M	73.95M	73.80M	73.74M	73.63M	73.62M	70.14M	70.10M	69.91M	69.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	70.23M	70.14M	70.12M	70.04M	69.93M	69.83M	69.82M	69.70M	69.54M	69.45M
Normalized Net Operating Profit after Tax (NOPAT)	99	82	38	53	102	53	30	27	18	2.03
Normalized NOPAT Margin	16.55%	15.14%	7.82%	12.08%	20.00%	12.24%	7.51%	7.48%	4.85%	0.60%
Pre Tax Income Margin	18.63%	15.24%	10.46%	12.43%	21.15%	12.41%	7.19%	6.87%	6.03%	-1.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.61	6.89	4.80	5.25	16.16	5.34	3.19	2.93	2.60	0.12
NOPAT to Interest Expense	11.37	6.70	18.32	4.99	15.22	5.09	3.07	2.85	1.87	0.22
EBIT Less CapEx to Interest Expense	6.17	4.52	2.54	3.01	11.45	3.18	1.32	1.65	-4.36	-3.57
NOPAT Less CapEx to Interest Expense	4.93	4.33	16.06	2.75	10.50	2.94	1.21	1.57	-5.10	-3.46
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Insulet's Financials

When does Insulet's fiscal year end?

According to the most recent income statement we have on file, Insulet's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Insulet's net income changed over the last 9 years?

Insulet's net income appears to be on an upward trend, with a most recent value of $418.30 million in 2024, falling from -$73.52 million in 2015. The previous period was $206.30 million in 2023. See Insulet's forecast for analyst expectations on what’s next for the company.

What is Insulet's operating income?

Insulet's total operating income in 2024 was $308.90 million, based on the following breakdown:

Total Gross Profit: $1.45 billion
Total Operating Expenses: $1.14 billion

How has Insulet revenue changed over the last 9 years?

Over the last 9 years, Insulet's total revenue changed from $263.89 million in 2015 to $2.07 billion in 2024, a change of 685.0%.

How much debt does Insulet have?

Insulet's total liabilities were at $1.88 billion at the end of 2024, a 1.1% increase from 2023, and a 678.2% increase since 2015.

How much cash does Insulet have?

In the past 9 years, Insulet's cash and equivalents has ranged from $0.00 in 2017 to $953.40 million in 2024, and is currently $953.40 million as of their latest financial filing in 2024.

How has Insulet's book value per share changed over the last 9 years?

Over the last 9 years, Insulet's book value per share changed from 0.60 in 2015 to 17.27 in 2024, a change of 2,787.9%.

Related Companies

This page (NASDAQ:PODD) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Insulet (PODD) Financials

Frequently Asked Questions About Insulet's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Insulet (PODD) Financials

Annual Income Statements for Insulet

Quarterly Income Statements for Insulet

Annual Cash Flow Statements for Insulet

Quarterly Cash Flow Statements for Insulet

Annual Balance Sheets for Insulet

Quarterly Balance Sheets for Insulet

Annual Metrics And Ratios for Insulet

Quarterly Metrics And Ratios for Insulet

Frequently Asked Questions About Insulet's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools